-
ST. NEOTS, UNITED KINGDOM - Nov 9, 2017 - Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications
Nov 9, 2017
-
MILFORD, MA - Nov 8, 2017 - SeraCare Life Sciences, a manufacturer and leading partner to global
in vitro
diagnostics manufacturers and clinical laboratories, is expanding what is already the most comprehensive suite of clinical genomics development, validation, and QC tools with the launch of the SeraseqTM Myeloid DNA and Myeloid RNA fusion reference materials: the industry's first comprehensive reference standards to help ensure the sensitivity and robustness of next-generation sequencing (NGS) based assays focused on myeloid cancers
Nov 8, 2017
-
WESTBURY, NY - Nov 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting
Nov 7, 2017
-
OXFORD, UNITED KINGDOM - Oct 31, 2017 -
Predictive and Efficacy Biomarkers in Cancer Research
In the run up to our 13th Annual Biomarkers Congress we are delighted to invite you to join our free pre-congress webinar
Oct 31, 2017
-
CAMBRIDGE, UK - Oct 27, 2017 - "As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable dataset," says Imad Yassin, Vice President of bio data management company Genestack
Oct 27, 2017
-
NATICK, MA, UNITED STATES - Oct 26, 2017 -
October 26, 2017 12:15 PM EST
Pillar Biosciences to Collaborate with Illumina on Next-Generation Sequencing Based In Vitro Diagnostics Development
Illumina and Pillar Biosciences, Inc
Oct 26, 2017
-
CRAIGAVON, N.I., UK - Oct 26, 2017 - Queens University Belfast have led the worlds largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation in how prostate cancer is diagnosed and treated
Oct 26, 2017
-
WESTBURY, NY - Oct 24, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017
Oct 24, 2017
-
WESTBURY, NY - Sep 21, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is increasing its support of the annual North American International Society for the Study of Xenobiotics (ISSX) Meeting
Sep 21, 2017
-
, AUSTRALIA - Sep 18, 2017 - SYDNEY, AUSTRALIA – (September 18, 2017). For a second time, SpeeDx Pty. Ltd., an Australian-based molecular diagnostics company, was awarded a grant from the New South Wales Medical Devices Fund (MDF)
Sep 18, 2017
-
SAN FRANCISCO, CA, UNITED STATES - Sep 18, 2017 -
Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine
San Francisco, CA - September 18, 2017
Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing and new investors iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford
Sep 18, 2017
-
MANCHESTER, UNITED KINGDOM - Sep 15, 2017 - Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics
Sep 15, 2017
-
HERSTAL, BELGIUM - Sep 11, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced results from a retrospective study published in The Prostate
,
demonstrating that SelectMDx® for Prostate Cancer, a non-invasive liquid biopsy test, correlates with multiparametric MRI (mpMRI) and outperforms the PCA3 test
Sep 11, 2017
-
CAMBRIDGE, UK - Sep 8, 2017 - Genestack is providing an essential missing link between data and its analysis, says Imad I. Yassin, recently appointed Vice President of Sales and Marketing for Genestack, the Cambridge-based biodata management company
Sep 8, 2017
-
CAMBRIDGE, UK - Sep 8, 2017 - It is now possible for non-bioinformaticians to create knowledge-networks – a powerful way for biologists to visualise deep connections between genes and phenotypes – quickly and efficiently thanks to the integration of Rothamsted Researchs open-source KnetMiner software into the Genestack platform
Sep 8, 2017
-
PRINCETON, NJ - Aug 15, 2017 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced today that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvante-ProPhase, the Groups electronic clinical outcomes assessment (eCOA) arm
Aug 15, 2017
-
WESTBURY, NY - Aug 10, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience, a global provider of high quality, well-characterized human tissue and research solutions with a focus on the oncology market
Aug 10, 2017
-
PRINCETON, NJ - Aug 2, 2017 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it has acquired Patient Genesis ConsentNow eConsent technology
Aug 2, 2017
-
MILFORD, MA - Aug 1, 2017 - SeraCare Life Sciences, a manufacturer and leading partner to global
in vitro
diagnostics manufacturers and clinical laboratories is announcing the launch of a set of unique Zika virus products as critical components of a robust QC program for validating and monitoring Zika virus test methods
Aug 1, 2017
-
WESTBURY, NY - Jul 31, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection
Jul 31, 2017